A 0 1 0 1 O
psychiatric 2 13 2 13 B-chronic_disease
disorder 14 22 14 22 I-chronic_disease
, 22 23 22 23 O
other 24 29 24 29 O
than 30 34 30 34 O
mild 35 39 35 39 B-chronic_disease
depression 40 50 40 50 I-chronic_disease
; 50 51 50 51 O
e.g. 52 56 52 56 O
schizophrenia 57 70 57 70 B-chronic_disease
, 70 71 70 71 O
bipolar 72 79 72 79 B-chronic_disease
disorder 80 88 80 88 I-chronic_disease
, 88 89 88 89 O
major 90 95 90 95 B-chronic_disease
depression 96 106 96 106 I-chronic_disease
, 106 107 106 107 O
panic 108 113 108 113 O
or 114 116 114 116 O
anxiety 117 124 117 124 B-chronic_disease
disorders 125 134 125 134 I-chronic_disease

Abnormal 0 8 135 143 O
lung 9 13 144 148 O
function 14 22 149 157 O
( 23 24 158 159 O
FEV1 24 28 159 163 B-clinical_variable
and 29 32 164 167 O
FVC 33 36 168 171 B-clinical_variable
< 37 38 172 173 O
80 39 41 174 176 B-upper_bound
% 41 42 176 177 I-upper_bound
predicted 43 52 178 187 O
) 52 53 187 188 O

Ages 0 4 189 193 B-age
18 5 7 194 196 B-lower_bound
- 7 8 196 197 O
70 8 10 197 199 B-upper_bound
years 11 16 200 205 I-upper_bound

Any 0 3 206 209 O
known 4 9 210 215 O
cardiac 10 17 216 223 B-chronic_disease
( 18 19 224 225 O
apart 19 24 225 230 O
from 25 29 231 235 O
treated 30 37 236 243 O
hypertension 38 50 244 256 B-chronic_disease
with 51 55 257 261 O
acceptable 56 66 262 272 O
drugs 67 72 273 278 O
, 72 73 278 279 O
see 74 77 280 283 O
below 78 83 284 289 O
) 83 84 289 290 O
, 84 85 290 291 O
pulmonary 86 95 292 301 B-chronic_disease
( 96 97 302 303 O
including 97 106 303 312 O
asthma 107 113 313 319 B-chronic_disease
) 113 114 319 320 O
, 114 115 320 321 O
renal 116 121 322 327 B-chronic_disease
, 121 122 327 328 O
neurologic 123 133 329 339 B-chronic_disease
( 134 135 340 341 O
including 135 144 341 350 O
epilepsy 145 153 351 359 B-chronic_disease
) 153 154 359 360 O
, 154 155 360 361 O
neuromuscular 156 169 362 375 B-chronic_disease
, 169 170 375 376 O
hepatic 171 178 377 384 B-chronic_disease
disease 179 186 385 392 I-chronic_disease
, 186 187 392 393 O
or 188 190 394 396 O
patients 191 199 397 405 O
with 200 204 406 410 O
diabetes 205 213 411 419 B-chronic_disease

Females 0 7 420 427 B-gender

History 0 7 428 435 O
of 8 10 436 438 O
driving 11 18 439 446 O
or 19 21 447 449 O
other 22 27 450 455 O
accidents 28 37 456 465 O
due 38 41 466 469 O
to 42 44 470 472 O
sleepiness 45 55 473 483 O
or 56 58 484 486 O
an 59 61 487 489 O
ESS 62 65 490 493 B-clinical_variable
> 66 67 494 495 O
18 68 70 496 498 B-lower_bound

Male 0 4 499 503 B-gender

More 0 4 504 508 O
than 5 9 509 513 O
10 10 12 514 516 B-lower_bound
cups 13 17 517 521 O
of 18 20 522 524 O
beverages 21 30 525 534 O
with 31 35 535 539 O
caffeine 36 44 540 548 O
( 45 46 549 550 O
coffee 46 52 550 556 O
, 52 53 556 557 O
tea 54 57 558 561 O
, 57 58 561 562 O
soda 59 63 563 567 O
/ 63 64 567 568 O
pop 64 67 568 571 O
) 67 68 571 572 O
per 69 72 573 576 O
day 73 76 577 580 O

No 0 2 581 583 O
other 3 8 584 589 O
sleep 9 14 590 595 B-chronic_disease
disorders 15 24 596 605 I-chronic_disease

Prior 0 5 606 611 B-treatment
or 6 8 612 614 I-treatment
current 9 16 615 622 I-treatment
use 17 20 623 626 I-treatment
of 21 23 627 629 I-treatment
melatonin 24 33 630 639 I-treatment

Severe 0 6 640 646 B-chronic_disease
OSA 7 10 647 650 I-chronic_disease
( 11 12 651 652 O
≥30 12 15 652 655 O
apnea 16 21 656 661 B-clinical_variable
hypopnea 22 30 662 670 I-clinical_variable
index 31 36 671 676 I-clinical_variable
) 36 37 676 677 O

Smokers 0 7 678 685 O
( 8 9 686 687 O
quit 9 13 687 691 O
≥ 14 15 692 693 O
1 16 17 694 695 B-lower_bound
year 18 22 696 700 I-lower_bound
ago 23 26 701 704 O
acceptable 27 37 705 715 O
) 37 38 715 716 O

Substantial 0 11 717 728 O
alcohol 12 19 729 736 O
( 20 21 737 738 O
> 21 22 738 739 O
3oz 22 25 739 742 B-lower_bound
/ 25 26 742 743 I-lower_bound
day 26 29 743 746 I-lower_bound
) 29 30 746 747 O
or 31 33 748 750 O
use 34 37 751 754 O
of 38 40 755 757 O
illicit 41 48 758 765 O
drugs 49 54 766 771 O

Use 0 3 772 775 O
of 4 6 776 778 O
any 7 10 779 782 O
medications 11 22 783 794 B-treatment
that 23 27 795 799 O
may 28 31 800 803 O
affect 32 38 804 810 O
sleep 39 44 811 816 O
or 45 47 817 819 O
breathing 48 57 820 829 O

Use 0 3 830 833 O
of 4 6 834 836 O
serotonin 7 16 837 846 B-treatment
reuptake 17 25 847 855 I-treatment
inhibitors 26 36 856 866 I-treatment
, 36 37 866 867 O
serotonin 38 47 868 877 B-treatment
- 47 48 877 878 I-treatment
norepinephrine 48 62 878 892 I-treatment
reuptake 63 71 893 901 I-treatment
inhibitors 72 82 902 912 I-treatment
, 82 83 912 913 O
ACE 84 87 914 917 B-treatment
inhibitors 88 98 918 928 I-treatment
or 99 101 929 931 O
any 102 105 932 935 O
drugs 106 111 936 941 O
which 112 117 942 947 O
interfere 118 127 948 957 O
with 128 132 958 962 O
the 133 136 963 966 O
renin 137 142 967 972 O
- 142 143 972 973 O
Angiotensin 143 154 973 984 O
system 155 161 985 991 O
, 161 162 991 992 O
Losartan 163 171 993 1001 B-treatment
( 172 173 1002 1003 O
or 173 175 1003 1005 O
other 176 181 1006 1011 O
Angiotensin 182 193 1012 1023 B-treatment
II 194 196 1024 1026 I-treatment
type 197 201 1027 1031 I-treatment
1 202 203 1032 1033 I-treatment
receptor 204 212 1034 1042 I-treatment
antagonists 213 224 1043 1054 I-treatment
) 224 225 1054 1055 O
, 225 226 1055 1056 O
non 227 230 1057 1060 B-treatment
- 230 231 1060 1061 I-treatment
specific 231 239 1061 1069 I-treatment
calcium 240 247 1070 1077 I-treatment
channel 248 255 1078 1085 I-treatment
blockers 256 264 1086 1094 I-treatment
( 265 266 1095 1096 O
L 266 267 1096 1097 O
channel 268 275 1098 1105 O
specific 276 284 1106 1114 O
are 285 288 1115 1118 O
acceptable 289 299 1119 1129 O
) 299 300 1129 1130 O
, 300 301 1130 1131 O
anti 302 306 1132 1136 B-treatment
- 306 307 1136 1137 I-treatment
inflammatories 307 321 1137 1151 I-treatment
, 321 322 1151 1152 O
vitamins 323 331 1153 1161 B-treatment
or 332 334 1162 1164 O
any 335 338 1165 1168 O
antioxidants 339 351 1169 1181 B-treatment

